Dear Mrs. Do Structured Products for investors in Switzerland
If this email is not displayed correctly, please click here.
 
Structured Products for investors in Switzerland
 
   
Dear Mrs. Do
Today UBS KeyInvest product news brings you up to date on our top new issues of the week.

Have we aroused your interest? Your client advisor looks forward to taking your order.
Kind regards

UBS KeyInvest Team
More about KeyInvest
KeyInvest Newsletters
Products in subscription
UBS services
Contacts
We are at your disposal

Tel +41 44 239 76 76 *
E-Mail
ubs.com/keyinvest
 
UBS Kick-In GOALs
If markets don't display clear trends, yield optimization strategies can be a good choice - Kick-In GOALs offer fixed coupons combined with contingent capital protection.
Product
Barrier
Currency
Subscription
Tenor
Termsheet
12.00% on Barrick Gold / Goldcorp / Newmont Mining
49%
USD
02.11.2016
1 Year(s)
11.75% on ABB / Meyer Burger / VAT

49%

CHF
02.11.2016
1 Year(s)
10.75% on Glencore / Rio Tinto / BHP Billiton

59%
USD (Quanto)

09.11.2016
1 Year(s)
9.25% on Basilea / Galenica / Roche

59%

CHF
02.11.2016
1 Year(s)
8.75% on Aryzta / Baloise / Sunrise

69%
CHF

09.11.2016
1 Year(s)
8.00% on Allianz / Axa / ING
59%

EUR

09.11.2016
1 Year(s)
8.00% on Bayer / SAP / Siemens
69%

EUR

02.11.2016
1 Year(s)
6.25% on Euro STOXX 50 / Nikkei 225 / S&P 500 / SMI
69%
CHF (Quanto)

02.11.2016
1 Year(s)
5.00% on Euro STOXX 50 / Hang Seng / SMI
69%
CHF (Quanto)
09.11.2016
1 Year(s)
 
UBS Early Redemption Kick-In GOALs
Early Redemption Worst of Kick-In GOALs offer an attractive coupon in return for not profiting from gains above the strike level. In addition, if all the underlyings close at or above their respective early redemption levels on any of the observation dates the product will redeem early.
Product
Barrier
Currency
Subscription
Tenor
Termsheet
12.25% on Enel / Eni / Intesa Sanpaolo

49%
EUR
02.11.2016
1 Year(s)
11.75% on Credit Suisse / Givaudan / Swatch
59%
CHF

02.11.2016
1 Year(s)
11.25% on BP / Eni / Royal Dutch Shell
69%
CHF (Quanto)
02.11.2016
1 Year(s)
9.75% on Alphabet / Apple / Facebook / Microsoft
49%
USD

09.11.2016
2 Year(s)

9.50% on Axa / Swiss Life / Zurich Insurance
64%
CHF (Quanto)
09.11.2016
1 Year(s)
9.00% on Nestle / Novartis / Roche / Zurich Insurance
69%
CHF
02.11.2016
1 Year(s)
8.25% on Peugeot / Renault / Porsche
49%
EUR
09.11.2016
1 Year(s)
7.75% on Actelion / Novartis / Roche / Swiss Re
64%
CHF
09.11.2016
1 Year(s)
7.50% on ABB / Sulzer / OC Oerlikon
69%
CHF (Quanto)
09.11.2016
1 Year(s)
7.50% on Amgen / Celgene / Gilead
49%
USD
02.11.2016
1 Year(s)
6.00% on AMS / Swatch / Sika
50%
CHF
09.11.2016
1 Year(s)
5.25% on Julius Bär / Credit Suisse / Swiss Life
49%
CHF
09.11.2016
1 Year(s)
 
 
     
  Visit our website at www.ubs.com/keyinvest  
  You have received this E-Newsletter because you subscribed to it on www.ubs.com/keyinvest under the e-mail address newsletter@newslettercollector.com.  
 
   Unsubscribe/Change | Register  
 
  Publication data
Sent by: UBS AG, Public Distribution Switzerland, CH-8098 Zürich
© UBS 2016, The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved
 
 
  * Please be aware that calls on the number marked with * can be recorded. By calling this number, we assume that you agree with this business practice.

These structured products do not constitute participation in a collective investment scheme within the meaning of Art. 7 et seq. of the Collective Investment Scheme Act (CISA) and are consequently not subject to the approval of the Swiss Financial Market Supervisory Authority (FINMA). Investors who invest in these products therefore do not have investor protection under the CISA. This e-mail is intended exclusively for informational purposes and should not be interpreted as an offer, personal recommendation or solicitation to conclude a transaction, nor should it be construed to constitute investment advisory services. This e-mail does not represent a simplified prospectus within the meaning of Art. 5 of the CISA or a listing notice within the meaning of the Listing Rules. The relevant product documentation can be obtained directly from UBS on tel. 044-239 47 03, fax 044-239 69 14 or by e-mail under swiss-prospectus@ubs.com. This issue may be subject to sales restrictions affecting Europe, Hong Kong, Singapore, the US and US citizens among others (the issue is subject to Swiss law). We recommend that you seek expert advice from your house bank before purchasing structured products. We accept no liability for the information provided in this advertisement.

Special Risks in Securities Trading

Based on previous e-mail correspondence with you and/or an agreement reached with you, UBS considers itself authorized to contact you via unsecured e-mail. Warning:
(a) E-mails can involve SUBSTANTIAL RISKS, e.g. lack of confidentiality, potential manipulation of contents and/or sender's address, incorrect recipient (misdirection), viruses etc. UBS assumes no responsibility for any loss or damage resulting from the use of e-mails. UBS recommends in particular that you do NOT SEND ANY SENSITIVE INFORMATION, that you do not include details of the previous message in any reply, and that you enter e-mail address(es) manually every time you write an e-mail.
(b) As a matter of principle, UBS does NOT accept any ORDERS, revocations of orders or authorizations, blocking of credit cards, etc., sent by e-mail. Should such an e-mail nevertheless be received, UBS is not obliged to act on or respond to the e-mail.Please notify UBS immediately if you received this e-mail by mistake or if you do not wish to receive any further e-mail correspondence. If you have received this e-mail by mistake, please completely delete it (and any attachments) and do not forward it or inform any other person of its contents.